Hostname: page-component-7b7567c8c-2n9c9 Total loading time: 0 Render date: 2026-11-16T22:34:56.404Z Has data issue: false hasContentIssue false

Healing soles: a microbiology-driven electronic health record-algorithm and order set to decrease antipseudomonal use in diabetic foot infections, a retrospective, observational, quasi-experimental study

Published online by Cambridge University Press:  27 March 2025

Antoinette Marie Acbo*
Affiliation:
Department of Pharmacy, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA
Naida Koura-Mola
Affiliation:
Department of Pharmacy, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA
Terrence McSweeney
Affiliation:
Department of Pharmacy, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA
Hongkai Bao
Affiliation:
Department of Pharmacy, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA
Mei Chang
Affiliation:
Department of Pharmacy, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA
Kelsie Cowman
Affiliation:
Network Performance Group, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA
Priya Nori
Affiliation:
Division of Infectious Diseases, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA
Yi Guo
Affiliation:
Department of Pharmacy, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA
*
Corresponding author: Antoinette Marie Acbo; Email: antoinette.acbo@rutgers.edu

Abstract

Background

Antipseudomonal antibiotics are commonly prescribed for diabetic foot infections (DFI) at our institution despite a low local prevalence of Pseudomonas aeruginosa. A multidisciplinary team implemented a DFI electronic health record (EHR)-embedded treatment algorithm and order set.

Methods

This multi-center, quasi-experimental study evaluated adults on antibiotics admitted for DFI to vascular surgery or medical units pre- and post-implementation of an EHR-embedded treatment algorithm and order set. Exclusion criteria: duplicate patients, concomitant infection, transfer from an outside hospital. Primary endpoint: antipseudomonal use among included patients (DOT/1000 DFI days present). Secondary outcomes: empiric antipseudomonal use, length of stay, 30-day readmission, mortality, amputation, and Clostridioides difficile infection. Patient demographics, diagnostics, treatments, and outcomes were evaluated.

Results

Two hundred ten patients were included with 70 patients included in each group. The post-algorithm group had lower antipseudomonal DOT/1000 DFI days present compared to the pre-intervention group (360 vs 503, P < 0.001). The post-order set group had the lowest antipseudomonal use (347 vs 503, P < 0.001). Empiric antipseudomonal use decreased from 85.7% pre-intervention to 72% post-algorithm and 68.5% post-order set. Collectively, 30-day mortality was < 5%. Amputation during and within 30 days of hospitalization was similar in the pre-intervention (48.6%), post-algorithm (30%), and post-order set (41.4%) groups. Methicillin-susceptible Staphylococcus aureus and Streptococcus spp. were most frequently isolated. Wound cultures were not collected in 24.3%, 22.9%, and 40% of the pre-intervention, post-algorithm, and post-order set group.

Conclusions

EHR-embedded clinical decision-making tools reduce antipseudomonal use for DFI treatment without increasing 30-day mortality or amputation.

Information

Type
Original Article
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
© The Author(s), 2025. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America
Figure 0

Figure 1.Inclusion and exclusion criteria.

Figure 1

Table 1.Baseline characteristics

Figure 2

Figure 2.Antipseudomonal DOT (days of therapy)/1000 DFI (diabetic foot infection) days present during the pre-intervention (left), post-algorithm (center), and post-order set (right) periods.

Figure 3

Table 2.Secondary outcomes

Supplementary material: File

Acbo et al. supplementary material 1

Acbo et al. supplementary material
Download Acbo et al. supplementary material 1(File)
File 6.4 MB
Supplementary material: File

Acbo et al. supplementary material 2

Acbo et al. supplementary material
Download Acbo et al. supplementary material 2(File)
File 467 KB